PHAXIAM Therapeutics S.A. (EPA:PHXM)
France flag France · Delayed Price · Currency is EUR
1.888
+0.018 (0.96%)
Feb 21, 2025, 3:57 PM CET

PHAXIAM Therapeutics Statistics

Total Valuation

EPA:PHXM has a market cap or net worth of EUR 19.03 million. The enterprise value is 21.82 million.

Market Cap 19.03M
Enterprise Value 21.82M

Important Dates

The next estimated earnings date is Thursday, March 13, 2025.

Earnings Date Mar 13, 2025
Ex-Dividend Date n/a

Share Statistics

EPA:PHXM has 10.01 million shares outstanding.

Current Share Class n/a
Shares Outstanding 10.01M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 0.72%
Owned by Institutions (%) 38.25%
Float 9.76M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -1.00
EV / Sales 10.19
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) n/a
Revenue Per Employee 31,485
Profits Per Employee -322,382
Employee Count 68
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -37.69% in the last 52 weeks. The beta is 1.70, so EPA:PHXM's price volatility has been higher than the market average.

Beta (5Y) 1.70
52-Week Price Change -37.69%
50-Day Moving Average 1.78
200-Day Moving Average 1.90
Relative Strength Index (RSI) 62.71
Average Volume (20 Days) 7,807

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, EPA:PHXM had revenue of EUR 2.14 million and -21.92 million in losses.

Revenue 2.14M
Gross Profit 2.14M
Operating Income -18.11M
Pretax Income -21.90M
Net Income -21.92M
EBITDA -18.90M
EBIT -18.11M
Earnings Per Share (EPS) n/a
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) n/a
Book Value Per Share n/a
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -845.73%
Pretax Margin -1,022.98%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

EPA:PHXM does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -115.22%
FCF Yield n/a

Stock Splits

The last stock split was on September 18, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date Sep 18, 2023
Split Type Reverse
Split Ratio 0.1

Scores

Altman Z-Score n/a
Piotroski F-Score n/a